Beijing Balance Medical Technology Co.,Ltd. (SHA:688198)

Market Cap	10.53B -37.2%
Revenue (ttm)	663.57M +26.2%
Net Income	202.44M +18.7%
EPS	1.47 +17.0%
Shares Out	137.75M
PE Ratio	52.07
Forward PE	n/a
Dividend	0.80 (1.03%)
Ex-Dividend Date	May 26, 2026

Volume	456,068
Open	76.10
Previous Close	76.08
Day's Range	75.50 - 76.99
52-Week Range	75.00 - 132.94
Beta	-0.01
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About SHA:688198

Beijing Balance Medical Technology Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of artificial bioprosthetic valve medical devices in China and internationally. It offers bovine pericardial, porcine aortic tissue, and limiting expandable artificial biological heart valves, as well as tricuspid annuloplasty ring for heart valve repair and treatment. The company also provides outflow tract single valve patch, pulmonary valved conduit, cardiothoracic biopatch, thoracic surgery biological patch...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 746
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688198

Financial Performance

In 2025, SHA:688198's revenue was 620.15 million, an increase of 23.57% compared to the previous year's 501.88 million. Earnings were 193.57 million, an increase of 32.28%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 25, 2026

Data Sources Report a data error